TREATMENT OF COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA IN PATIENTS WITH RENAL IMPAIRMENT: OUTCOMES FROM A GLOBAL PHASE-3 STUDY OF DELAFLOXACIN | Publicación